Calton & Associates’s Hologic HOLX Stock Holding History

Calton & Associates’s Portfolio HOLX Stock Details HOLX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-68	Closed	-$2K	–	744
2017 Q4	$2K	Buy	+68	New	+$2.71K	﹤0.01%	1393

Other funds holding HOLX

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Parnassus Investments San Francisco, California $37.4B AUM 35.42% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $178B AUM 37.23% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Calton & Associates's HOLX Position: Q1 2018 in Review

Calton & Associates sold out of Hologic (HOLX) in Q1 2018, closing a stake of 68 shares — an estimated $2K sold.

Calton & Associates first reported a position in HOLX in Q4 2017 and held it in 1 quarter. The position peaked at $2K in Q4 2017. 463 funds tracked by Wall St. Rank hold HOLX as of Q1 2018.

Calton & Associates reported no remaining Hologic position as of Q1 2018 after selling out during the quarter.
Calton & Associates sold 68 Hologic shares in Q1 2018, an estimated $2K.
Calton & Associates first reported a position in Hologic in Q4 2017 and held it in 1 quarter.
Calton & Associates's Hologic position peaked at $2K in Q4 2017.
463 funds tracked by Wall St. Rank held Hologic as of Q1 2018.

Based on Calton & Associates's 13F filing for Q1 2018, filed 17 Apr 2018.